指南与共识腹部CTMR

影像组学模型与2017年修订版国际共识指南预测恶性导管内乳头状黏液性肿瘤的比较

Radiomics model versus 2017 revised international consensus guidelines for predicting malignant intraductal papillary mucinous neoplasms.
指南 / 共识 · Eur Radiol · 2023-08-24

回顾性纳入194例手术切除的胰腺导管内乳头状黏液性肿瘤患者,基于术前增强CT构建影像组学模型并与2017年国际共识指南比较。验证集中影像组学模型AUC 0.85高于指南的0.71(P=0.038),特异度84.6%高于61.5%(P=0.041),阳性预测值84.0%高于66.7%(P=0.044)。

要点

  • 验证集中CT影像组学模型AUC 0.85,高于2017年国际共识指南的0.71(P=0.038)。
  • 2017年国际共识指南在CT与MRI间诊断性能无显著差异(AUC 0.71 vs 0.71,P=0.93),模态间一致性极好(k=0.86)。
  • 影像组学模型可能作为2017年国际共识指南的有价值补充工具,有望实现更定量的评估。

核心结论

  • CT影像组学模型在鉴别恶性导管内乳头状黏液性肿瘤方面诊断性能优于2017年国际共识指南。

研究设计与样本

  • 回顾性纳入2008年1月至2020年12月间连续194例接受手术切除的胰腺导管内乳头状黏液性肿瘤患者,以手术组织病理学为诊断恶性参考标准。

诊断标准与关键数值

  • 验证集中CT影像组学模型AUC 0.85 vs 2017年国际共识指南AUC 0.71(P=0.038),特异度84.6% vs 61.5%(P=0.041),阳性预测值84.0% vs 66.7%(P=0.044)。

临床应用与阅片要点

  • 影像组学模型可能作为2017年国际共识指南的有价值补充工具,有望实现对导管内乳头状黏液性肿瘤更定量的评估。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate a CT-based radiomics model for identifying malignant pancreatic intraductal papillary mucinous neoplasms (IPMNs) and compare its performance with the 2017 international consensus guidelines (ICGs).

MATERIALS AND METHODS: We retrospectively included 194 consecutive patients who underwent surgical resection of pancreatic IPMNs between January 2008 and December 2020. Surgical histopathology was the reference standard for diagnosing malignancy. Using radiomics features from preoperative contrast-enhanced CT, a radiomics model was built with the least absolute shrinkage and selection operator by a five-fold cross-validation. CT and MR images were independently reviewed based on the 2017 ICGs by two abdominal radiologists, and the performances of the 2017 ICGs and radiomics model were compared. The areas under the curve (AUCs) were compared using the DeLong method.

RESULTS: A total of 194 patients with pancreatic IPMNs (benign, 83 [43%]; malignant, 111 [57%]) were chronologically divided into training (n = 141; age, 65 ± 8.6 years; 88 males) and validation sets (n = 53; age, 66 ± 9.7 years; 31 males). There was no statistically significant difference in the diagnostic performance of the 2017 ICGs between CT and MRI (AUC, 0.71 vs. 0.71; p = 0.93) with excellent intermodality agreement (k = 0.86). In the validation set, the CT radiomics model had higher AUC (0.85 vs. 0.71; p = 0.038), specificity (84.6% vs. 61.5%; p = 0.041), and positive predictive value (84.0% vs. 66.7%; p = 0.044) than the 2017 ICGs.

CONCLUSION: The CT radiomics model exhibited better diagnostic performance than the 2017 ICGs in classifying malignant IPMNs.

CLINICAL RELEVANCE STATEMENT: Compared with the radiologists' evaluation based on the 2017 international consensus guidelines, the CT radiomics model exhibited better diagnostic performance in classifying malignant intraductal papillary mucinous neoplasms.

KEY POINTS: • There is a paucity of comparisons between the 2017 international consensus guidelines (ICGs) and radiomics models for malignant intraductal papillary mucinous neoplasms (IPMNs). • The CT radiomics model developed in this study exhibited better diagnostic performance than the 2017 ICGs in classifying malignant IPMNs. • The radiomics model may serve as a valuable complementary tool to the 2017 ICGs, potentially allowing a more quantitative assessment of IPMNs.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Lee DY, Shin J, Kim S, et al. Radiomics model versus 2017 revised international consensus guidelines for predicting malignant intraductal papillary mucinous neoplasms. Eur Radiol. 2023. PMID: 37615762. doi:10.1007/s00330-023-10158-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。